«Previous Article|Table of Contents|Next Article»

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:

2024 23

Page:

4413-4424

Research Field:

Publishing date:

Info

Title:

Chinese expert consensus on the diagnosis and treatment of endometrial cancer in the elderly

Author(s):

LIU Tingting¹; KONG Weimin¹; GAO Guolan²; CHEN Aiping³; GAO Jun⁴

Gynecology Branch of the Chinese Society of Gerontology and Geriatrics (1.Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University,Beijing Maternal and Child Health Hospital,Beijing 100006£¬China;2.West China Second Hospital,Sichuan University,Sichuan Chengdu 610016,China;3.Affiliated Hospital of Qingdao University,Shandong Qingdao 266000,China;4.Jiangxi Cancer Hospital,Jiangxi Nanchang 330006,China.)

Keywords:

endometrial cancer; elderly women; China; expert consensus

PACS:

R737.33

DOI:

10.3969/j.issn.1672-4992.2024.23.001

Abstract:

Endometrial cancer is one of the most common gynecological malignancies.As the aging population continues to increase,China's population structure will move from mild aging to moderate aging,and the number of elderly patients with endometrial cancer will increase year by year.Since the disease characteristics and prognosis of endometrial cancer in the elderly are different from those in young and middle-aged patients,and elderly patients have many comorbidities and limited tolerance to various treatments,treatment measures should have their own particularities.However,there is currently a lack of relevant guidelines and expert consensus,and there is an urgent need to issue guidance specifically for the diagnosis and treatment of endometrial cancer in the elderly.Therefore,the Gynecology Branch of the Chinese Society of Gerontology and Geriatrics organized experts to form the following expert consensus on the diagnosis and treatment of endometrial cancer in elderly Chinese women based on evidence-based medicine and combined with clinical diagnosis and treatment experience,aiming to standardize the diagnosis and treatment decisions of endometrial cancer in elderly Chinese women and guide clinical practice.

References:

£Û1£ÝSUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries£ÛJ£Ý.CA Cancer J Clin,2021,71(3):209-249.
£Û2£ÝCROSBIE EJ,KITSON SJ,MCALPINE JN,et al.Endometrial cancer£ÛJ£Ý.Lancet,2022,399(10333):1412-1428.
£Û3£ÝISLAMI F,WARD EM,SUNG H,et al.Annual report to the nation on the status of cancer,part 1:National Cancer Statistics£ÛJ£Ý.J Natl Cancer Inst,2021,113(12):1648-1669.
£Û4£Ý¹ú¼Òͳ¼Æ¾Ö.µÚÆß´ÎÈ«¹úÈË¿ÚÆղ鹫±¨£ÛZ/OL£Ý.(2021-05-11)£Û2021-12-10£Ý.http£º//www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/202106/t20210628_1818824.html. National Bureau of Statistics.Communiqu¨¦ of the Seventh National Population Census£ÛZ/OL£Ý.(2021-05-11)£Û2021-12-10£Ý.http£º//www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/202106/t20210628_1818824.html.
£Û5£ÝÊ¢ÒàÄÐ,¹Ë´óÄÐ.¸ÅÂÊÈË¿ÚÔ¤²â·½·¨¼°ÆäÓ¦Ó᪡¶ÊÀ½çÈË¿ÚÕ¹Íû¡·¸ÅÂÊÈË¿ÚÔ¤²â·½·¨¼ò½é£ÛJ£Ý.ÈË¿Úѧ¿¯,2020,42(5):31-46. SHENG YN,GU DN.Probabilistic population forecasting methods and their applications-introduction to probabilistic population forecasting methods in¡¶World Population Prospects¡·£ÛJ£Ý.Population Journal,2020,42(5):31-46.
£Û6£ÝRICHARD R BARAKAT.¸¾¿ÆÖ×ÁöѧԭÀíÓëʵ¼ù£ÛM£Ý.ÁÖÖÖÇï,À,Òë.5°æ.±±¾©:ÈËÃñÎÀÉú³ö°æÉç,2012:760-762. RICHARD R BARAKAT.Principles and practice of gynecological oncology£ÛM£Ý.LIN ZQ,LI J,translate.5th edition.Beijing:People's Health Publishing House,2012:760-762.
£Û7£ÝHAG-YAHIA N,GEMER O,EITAN R,et al.Age is an independent predictor of outcome in endometrial cancer patients:An Israeli Gynecology Oncology Group cohort study£ÛJ£Ý.Acta Obstet Gynecol Scand,2021,100(3):444-452.
£Û8£ÝÕÔÎÄÈÙ,³Ì¾²ÐÂ.ÀÏÄê×Ó¹¬ÄÚĤ°©µÄÕïÁƲßÂÔ£Û J£Ý.ʵÓø¾²ú¿ÆÔÓÖ¾,2019,35(8):567-570. ZHAO WR,CHENG JX.Diagnosis and treatment strategies for elderly endometrial cancer£ÛJ£Ý.Journal of Practical Obstetrics and Gynecology,2019,35(8):567-570.
£Û9£Ý·ëÃîФ,É£Ð㲨,³Â˵,µÈ.×Ó¹¬ÄÚĤ°©µÄÔ¤ºóÒòËØ·ÖÎö£Û J£Ý.½âÆÊ¿Æѧ½øÕ¹,2016,22(1):35-38. FENG MX,SANG XB,CHEN S,et al.Analysis of prognosis factors in endometrial carcinoma£ÛJ£Ý.Progress of Anatomical Sciences,2016,22(1):35-38.
£Û10£ÝNational Comprehensive Cancer Network.NCCN clinical practice guidelines in oncology:Uterine Neoplasms.version.1.2024£ÛEB/OL£Ý.2024£¬MS1-MS36£Û2024-5-1£Ý.https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1473.
£Û11£ÝAUNE D,NAVARRO ROSENBLATT DA,CHAN DS,et al.Anthropometric factors and endometrial cancer risk:A systematic review and dose-response meta-analysis of prospective studies£ÛJ£Ý.Ann Oncol,2015,26:1635-1648.
£Û12£ÝãÆ»ÛÃô,ÕÅ÷,ÕÅЦ,µÈ.ÖйúÀÏÄêÈË´úл×ÛºÏÕ÷Á÷ÐÐÌØÕ÷¼°ÆäÓ°ÏìÒòËØÑо¿£ÛJ£Ý.ÖлªÁ÷Ðв¡Ñ§ÔÓÖ¾,2019,40(3):284-289. YAN HM,ZHANG M,ZHANG X,et al.Study of epidemiological characteristics of metabolic syndrome and influencing factors in elderly people in China£ÛJ£Ý.Clin J Epidemiol,2019,40(3):284-289.
£Û13£ÝÍõ·Ò·Ò,лÐÒ.×Ó¹¬ÄÚĤ°©µÄ²¡Òò¼°¸ßΣÒòËØ£ÛJ£Ý.ʵÓø¾²ú¿ÆÔÓÖ¾,2020,36(6):401-403. WANG FF,XIE X.The etiology and high-risk factors of endometrial cancer£ÛJ£Ý.Journal of Practical Obstetrics and Gynecology,2020,36(6):401-403.
£Û14£ÝYU K,HUANG ZY,XU XL,et al.Estrogen receptor function:Impact on the human endometrium£ÛJ£Ý.Front Endocrinol(Lausanne),2022,13:827724.
£Û15£ÝDOMINGUEZ-VALENTIN M,SAMPSON JR,SEPP¦FL¦F TT,et al.Cancer risks by gene,age,and gender in 6350 carriers of pathogenic mismatch repair variants:findings from the Prospective Lynch Syndrome Database£ÛJ£Ý.Genet Med,2020,22:15-25.
£Û16£ÝDE JONGE MM,DE KROON CD,JENNER DJ,et al.Endometrial cancer risk in women with germline BRCA1 or BRCA2 mutations:Multicenter cohort study£ÛJ£Ý.J Natl Cancer Inst,2021,113:1203-1211.
£Û17£ÝGREDMARK T,KVINT S,HAVEL G,et al.Histopathological findings in women with postmenopausal bleeding£ÛJ£Ý.Br J Obstet Gynaecol,1995,102:133-136.
£Û18£ÝлÁáÁá,ÁÖÈÙ´º,ÁÖÖÙÇï.¹ú¼ÊȨÍþ×Ó¹¬ÄÚĤ°©ÕïÖÎÖ¸ÄϽâ¶Á£ÛJ£Ý.ʵÓø¾²ú¿ÆÔÓÖ¾,2020,36(06):428-432. XIE LL,LIN RC,LIN ZQ.Interpretation of International Authoritative Guidelines for Diagnosis and Treatment of Endometrial Cancer£ÛJ£Ý.Journal of Practical Obstetrics and Gynecology,2020,36(06):428-432.
£Û19£ÝÀîСë,Ò¶»Ôϼ,ÑîÏþ»Ô,µÈ.60ËêÒÔÉÏ×Ó¹¬ÄÚĤ°©ÁÙ´²²¡Àí·ÖÎö£ÛJ£Ý.ÏÖ´ú¸¾²ú¿Æ½øÕ¹,2015,24(05):354-356. LI XM,YE HX,YANG XH,et al.Clinical and pathological analysis of endometrial cancer over 60 years old£ÛJ£Ý.Prog Obstet Gynecol,2015,24(05):354-356.
£Û20£ÝKANDOTH C,SCHULTZ N,CHERNIACK AD,et al.Integrated genomic characterization of endometrial carcinoma£ÛJ£Ý.Nature,2013,497(7447):67-73.
£Û21£ÝÖйúÑо¿ÐÍҽԺѧ»á¸¾²ú¿ÆѧרҵίԱ»á.×Ó¹¬ÄÚĤ°©·Ö×Ó·ÖÐÍÁÙ´²Ó¦ÓÃÖйúר¼Ò¹²Ê¶£¨2024Äê°æ£©£ÛJ£Ý.ÖйúʵÓø¾¿ÆÓë²ú¿ÆÔÓÖ¾£¬2024,40(6)£º638-644. Chinese Research Hospital Association Obstetrics and Gynecology Professional Committee.Chinese Expert Consensus on Clinical Application of Molecular Typing of Endometrial Cancer(2024 Edition)£ÛJ£Ý.Chinese Journal of Practical Gynecology and Obstetrics,2024,40(6):638-644.
£Û22£ÝËïÀöÀö,Áõ¸ñµ¤,¼Öéª,µÈ.²»Í¬·Ö×Ó·ÖÐ͵Ä×Ó¹¬ÄÚĤ°©ÁÙ´²²¡ÀíÌØÕ÷·ÖÎö£ÛJ£Ý.Ö×ÁöÔ¤·ÀÓëÖÎÁÆ,2022,35(5):435-441. SUN LL,LIU GD,JIA N,et al.Clinicopathological features of endometrial cancer with different molecular types£ÛJ£Ý.J Cancer Control Treat,2022,35(5):435-441.
£Û23£ÝÀ,ÁÖÖÙÇï.×Ó¹¬ÄÚĤ°©°©Ö¢»ùÒò×éͼÆ×·Ö×Ó·ÖÐͶÔÁÙ´²Õï¶Ï¡¢Ô¤ºóÅжϼ°Êõºó´¦ÀíµÄÓ°Ïì£ÛJ£Ý.ÖйúʵÓø¾¿ÆÓë²ú¿ÆÔÓÖ¾,2023,39(11):1080-1086. LI J,LIN ZQ.The impact of molecular typing of endometrial cancer genomic map on clinical diagnosis,prognosis,and postoperative management£ÛJ£Ý.Chinese Journal of Practical Gynecology and Obstetrics,2023,39(11):1080-1086.
£Û24£ÝÄôÓí·Æ,¹ùºìÑà,¸ßåû,µÈ.×Ó¹¬ÄÚĤ°©·Ö×Ó·ÖÐÍÓë·ÊÅÖ¼°´úлÒì³£ºÏ²¢Ö¢µÄ¹Øϵ£ÛJ£Ý.ʵÓø¾²ú¿ÆÔÓÖ¾,2022,38(7):555-558. NIE YF,GUO HY,GAO Y,et al.The relationship between molecular subtypes of endometrial cancer and comorbidities of obesity and metabolic abnormalities£ÛJ£Ý.Journal of Practical Obstetrics and Gynecology,2022,38(7):555-558.
£Û25£ÝÓá÷,ÏòÑô£¬ÂíÏþÐÀ£¬µÈ.×Ó¹¬ÄÚĤ°©É¸²é¹æ·¶»¯½¨Òé£ÛJ£Ý.Öлª¸¾²ú¿ÆÔÓÖ¾£¬2020,55(05):307-311. YU M,XIANG Y,MA XX,et al.Suggestions for Standardization of Endometrial Cancer Screening£ÛJ£Ý.Chinese Journal of Obstetrics and Gynecology,2020,55(05):307-311.
£Û26£ÝÑîºì.×Ó¹¬ÄÚĤ°©É¸²é²ßÂÔ£ÛJ£Ý.ÖйúʵÓø¾¿ÆÓë²ú¿ÆÔÓÖ¾,2023,39(11):1062-1065. YANG H.Screening strategy for endometrial cancer£ÛJ£Ý.Chinese Journal of Practical Gynecology and Obstetrics,2023,39(11):1062-1065.
£Û27£ÝKOSKAS M,AMANT F,MIRZA MR,et al.Cancer of the corpus uteri:2021 update£ÛJ£Ý.Int J Gynaecol Obstet,2021(Suppl 1):45-60.
£Û28£ÝÖйúҽʦЭ»á΢´´Ò½Ñ§×¨ÒµÎ¯Ô±»á¸¾¿ÆÖ×Áöѧ×é,ÖйúҽԺЭ»á¸¾²úÒ½Ôº·Ö»á¸¾¿ÆÖ×Áöרҵѧ×é,ÖйúÓÅÉú¿ÆѧЭ»áÖ×ÁöÉúֳѧ·Ö»á.×Ó¹¬ÄÚĤ½¬ÒºÐÔ°©ÕïÖεÄÖйúר¼Ò¹²Ê¶(2022Äê°æ)£ÛJ£Ý.°©Ö¢½øÕ¹,2022,20(9):865-874,879. The Gynecological Oncology Group of the Minimally Invasive Medicine Professional Committee of the Chinese Medical Association,the Gynecological Oncology Professional Group of the Obstetrics and Gynecology Hospital Branch of the Chinese Hospital Association,and the Tumor Reproduction Branch of the Chinese Eugenics Association.Chinese Expert Consensus on the Diagnosis and Treatment of Endometrial Serous Cancer(2022 Edition)£ÛJ£Ý.Cancer Progression,2022,20(9):865-874,879.
£Û29£ÝSUNDAR S,BALEGA J,CROSBIE E,et al.BGCS uterine cancer guidelines£ºRecommendations for practice£ÛJ£Ý.Eur J Obstet Gynecol Reprod Biol,2017,213:71-97.
£Û30£ÝÖлªÈËÃñ¹²ºÍ¹ú¹ú¼ÒÎÀÉú½¡¿µÎ¯Ô±»á.×Ó¹¬ÄÚĤ°©ÕïÖι淶(2018Äê°æ)£ÛJ£Ý.Ö×Áö×ÛºÏÖÎÁƵç×ÓÔÓÖ¾,2020,6(4):25-35. National Health Commission of the People's Republic of China.Guidelines for Diagnosis and Treatment of Endometrial Cancer(2018 Edition)£ÛJ£Ý.Journal of Comprehensive Cancer Therapy,2020,6(4):25-35.
£Û31£ÝHEFLER L,LAFLEUR J,KICKMAIER S,et al.Risk of endometrial cancer in asymptomatic postmenopausal patients with thickened endometrium:Data from the FAME-Endo study:An observational register study£ÛJ£Ý.Arch Gynecol Obstet,2018,298(4):813-820.
£Û32£ÝÐìÜçÜç,ÖÜȺӢ.¾ø¾­ºóÎÞÖ¢×´×Ó¹¬ÄÚĤÔöºñÅ®ÐÔÁÙ´²²¡ÀíÌØÕ÷·ÖÎö£ÛJ£Ý.Öйú¼Æ»®ÉúÓýѧÔÓÖ¾,2022,30(8):1911-1914,1919. XU QQ,ZHOU QY.Clinical and pathological characteristics analysis of asymptomatic endometrial thickening in postmenopausal women£ÛJ£Ý.Chinese Journal of Family Planning,2022,30(8):1911-1914,1919.
£Û33£ÝNational Comprehensive Cancer Network.NCCN Guidelines Older Adult Oncology.Version1.2024£ÛEB/OL£Ý.£Û2024-5-1£Ý.https://www.nccn.org/professionals/physician_gls/pdf/older_adult.pdf.
£Û34£Ý³ÂÈñ,³Ì¾²ÐÂ.ÀÏÄ긾¿ÆÖ×Áö»¼Õß¾ö²ß;¾¶¼°×ÛºÏÆÀ¹ÀÖ¸ÄÏÒªµã½â¶Á£ÛJ£Ý.ʵÓø¾²ú¿ÆÔÓÖ¾,2019,35(8):581-583. CHEN R,CHENG JX.Interpretation of decision-making pathways and comprehensive evaluation guidelines for elderly gynecological cancer patients£ÛJ£Ý.Journal of Practical Obstetrics and Gynecology,2019,35(8):581-583.
£Û35£ÝMOHANTY S,ROSENTHAL RA,RUSSELL MM,et al.Optimal Perioperative Management of the Geriatric Patient:A Best Practices Guideline from the American College of Surgeons NSQIP and the American Geriatrics Society£ÛJ£Ý.J Am Coll Surg,2016,222(5):930-947.
£Û36£ÝÖìÃùÀ×,»ÆÓî¹â,ÁõÏþºì,µÈ.ÀÏÄ껼ÕßΧÊÖÊõÆÚ¹ÜÀí±±¾©Ð­ºÍҽԺר¼Ò¹²Ê¶£ÛJ£Ý.ЭºÍҽѧÔÓÖ¾,2018,9(1):36-41. ZHU ML,HUANG YG,LIU XH,et al.Expert Consensus on Perioperative Management of Elderly Patients at Peking Union Medical College Hospital£ÛJ£Ý.Medical Journal of Peking Union Medical College Hospital,2018,9(1):36-41.
£Û37£ÝÖìÐÀ,ÕÅè¤.ÀÏÄ긾¿ÆÖ×Áö»¼ÕßΧÊÖÊõÆÚ¹ÜÀí¼°ÊÖÊõ¼ÓËÙ¿µ¸´£ÛJ£Ý.ʵÓø¾²ú¿ÆÔÓÖ¾,2019,35(8):576-577. ZHU X,ZHANG Y.Perioperative management and accelerated recovery of elderly gynecological cancer patients£ÛJ£Ý.Journal of Practical Obstetrics and Gynecology,2019,35(8):576-577.
£Û38£ÝHORNOR MA,MA M,ZHOU L,et al.Enhancing the American College of Surgeons NSQIP Surgical Risk Calculator to predict geriatric outcomes£ÛJ£Ý.J Am Coll Surg,2020,230:88-100.
£Û39£ÝZHOU L,GUO F,LI D,et al.Short-and long-term outcomes of laparoscopic surgery for elderly patients with clinical stage I endometrial cancer£ÛJ£Ý.J BUON,2020,25(2):764-771.
£Û40£ÝCORRADO G,VIZZA E,PERRONE AM,et al.Comparison between laparoscopic and robotic surgery in elderly patients with endometrial cancer:A retrospective multicentric study£ÛJ£Ý.Front Oncol,2021,11:724886.
£Û41£ÝDE BOER SM,POWELL ME,MILESHKIN L,et al.Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer(PORTEC-3):Patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial£ÛJ£Ý.Lancet Oncol,2019,20:1273-1285.
£Û42£ÝMILLER DS,FILIACI VL,MANNEL RS,et al.Carboplatin and paclitaxel for advanced endometrial cancer:Final overall survival and adverse event analysis of a phase ¢ó trial(NRG Oncology/GOG0209)£ÛJ£Ý.J Clin Oncol,2020,38:3841-3850.
£Û43£ÝÁÖÓêè¯,ÍõÔª¾°,¿×ΪÃñ.2023ÄêÃÀ¹ú·ÅÉäÖ×Áöѧ»á×Ó¹¬ÄÚĤ°©·ÅÉäÖÎÁÆÁÙ´²Êµ¼ùÖ¸ÄϽâ¶Á£ÛJ£Ý.ÖйúÁÙ´²Ò½ÉúÔÓÖ¾,2023,51(11):1284-1289. LIN YX,WANG YJ,KONG WM.Interpretation of the 2023 American Society of Radiation Oncology Clinical Practice Guidelines for Radiotherapy for Endometrial Cancer£ÛJ£Ý.Chinese Journal of Clinical Physicians,2023,51(11):1284-1289.
£Û44£ÝHARKENRIDER MM,ABU-RUSTUM N,ALBUQUERQUE K,et al.Radiation therapy for endometrial cancer:An American society for radiation oncology clinical practice guideline£ÛJ£Ý.Pract Radiat Oncol,2023,13(1):41-65.
£Û45£ÝMEIXNER E,LANG K,K¦ZNIG L,et al.Postoperative radiotherapy for endometrial cancer in elderly(¡Ý80 years) patients:Oncologic outcomes,toxicity,and validation of prognostic scores£ÛJ£Ý.Cancers(Basel),2021,13(24):6264.
£Û46£ÝÁõÉÜÓ±,·¶µä,Ö£²©ºÀ,µÈ.×Ó¹¬ÄÚĤ°©°ÐÏòÖÎÁÆнøÕ¹ÓëÇ°ÑØÕ¹Íû£ÛJ£Ý.Öйú°©Ö¢·ÀÖÎÔÓÖ¾,2021,13(2):121-125. LIU SY,FAN D,ZHENG BH,et al.New progress and frontier prospects of targeted therapy for endometrial cancer£ÛJ£Ý.Clin J of Oncol Prev and Treat,2021,13(2):121-125.
£Û47£ÝлÁáÁá,ÁÖÖÙÇï.¡¶2024 NCCN×Ó¹¬Ö×ÁöÁÙ´²Êµ¼ùÖ¸ÄÏ£¨µÚ1°æ£©¡·½â¶Á£ÛJ£Ý.ÖйúʵÓø¾¿ÆÓë²ú¿ÆÔÓÖ¾,2023,39(11):1122-1127. XIE LL,LIN ZQ.Interpretation of the 2024 NCCN Clinical Practice Guidelines for Uterine Tumors(First Edition)£ÛJ£Ý.Chinese Journal of Practical Gynecology and Obstetrics,2023,39(11):1122-1127.
£Û48£ÝÁõ´¨,ÀîÐãÇÙ.ÍíÆÚ/¸´·¢×Ó¹¬ÄÚĤ°©µÄÃâÒß°ÐÏòÖÎÁÆ£ÛJ£Ý.ÖйúʵÓø¾¿ÆÓë²ú¿ÆÔÓÖ¾,2023,39(11):1095-1098. LIU C,LI XQ.Immunotherapy and targeted therapy for advanced/recurrent endometrial carcinoma£ÛJ£Ý.Chinese Journal of Practical Gynecology and Obstetrics,2023,39(11):1095-1098.
£Û49£ÝYANG F,MARKOVIC SN,MOLINA JR,et al.Association of sex,age,and Eastern Cooperative Oncology Group Performance Status with survival benefit of cancer immunotherapy in randomized clinical trials:A systematic review and Meta-analysis£ÛJ£Ý.JAMA Netw Open,2020,3:e2012534.
£Û50£ÝÌïºìÑÞ.×Ó¹¬ÄÚĤ°©µÄÖÐÒ½Ö¤ÐÍÓëÔ¤ºó¹ØϵÑо¿£ÛJ£Ý.ÏÖ´úÖÐÒ½Ò©,2018,38(6):40-43. TIAN HY.Research on the relationship between traditional Chinese Medicine syndrome types and prognosis of endometrial cancer£ÛJ£Ý.Modern Traditional Chinese Medicine,2018,38(6):40-43.
£Û51£ÝÏÄ»ªÃô,½¯Ê¿Çä.½¯Ê¿ÇäÖÎÁÆ×Ó¹¬ÄÚĤ°©¾­ÑédzÎö£ÛJ£Ý.ÖйúÃñ¼äÁÆ·¨,2022,28(6):18-19. XIA HM,JIANG SQ.Analysis of Jiang Shiqing's experience in treating endometrial cancer£ÛJ£Ý.China's Naturopathy,2022,28(6):18-19.
£Û52£Ý»Æ½ÜÌØ,ºé½ðÄÝ,ºúÃöÏæ,µÈ.ÖÐÒ©×¢Éä¼ÁÔÚ×Ó¹¬ÄÚĤ°©¸¨ÖúÖÎÁÆÖеÄÁÙ´²Ó¦ÓãÛJ£Ý.ÖйúÃñ¼äÁÆ·¨,2022,30(16):113-115. HUANG JT,HONG JN,HU MX,et al.Clinical application of traditional Chinese Medicine injection in adjuvant treatment of endometrial cancer£ÛJ£Ý.China's Naturopathy,2022,30(16):113-115.
£Û53£ÝÖйú¿¹°©Ð­»áÖ×ÁöÓªÑøרҵίԱ»á.×Ó¹¬ÄÚĤ°©»¼ÕßµÄÓªÑøÖÎÁÆר¼Ò¹²Ê¶£ÛJ£Ý.Ö×Áö´úлÓëÓªÑøµç×ÓÔÓÖ¾,2020,7(4):415-417. Chinses Society of Nutritional Oncology.Expert Consensus on Nutritional Therapy for Patients with Endometrial Cancer£ÛJ£Ý.Electron J Metab Nutr Cancer,2020,7(4):415-417.

Memo

Memo:

-

Common functions

Last Update: 2024-11-01